| Schedule of Balance Sheets |
Condensed
Balance Sheets
| | |
October 31,
2025 | | |
October 31,
2024 | |
| ASSETS | |
| | |
| |
| Current
Assets | |
| | | |
| | |
| Cash | |
| 2,056,270 | | |
| — | |
| Other
receivables and other current assets | |
| 293,333 | | |
| — | |
| Deffered
IPO Cost | |
| — | | |
| 1,088,400 | |
| Total
Current Assets | |
| 2,349,603 | | |
| 1,088,400 | |
| Non-Current
Assets | |
| — | | |
| — | |
| Investment
in subsidiaries and VIEs | |
| 3,716,103 | | |
| 1,879,477 | |
| Total
Non-Current Assets | |
| 3,716,103 | | |
| 1,879,477 | |
| TOTAL
ASSETS | |
| 6,065,706 | | |
| 2,967,877 | |
| | |
| | | |
| | |
| LIABILITIES
AND SHAREHOLDERS’ EQUITY | |
| | | |
| | |
| Current
Liabilities | |
| | | |
| | |
| Accruals
and other payables | |
| 60,000 | | |
| — | |
| Intercompany
Payable | |
| 2,010,851 | | |
| 1,461,792 | |
| Total
Current Liabilities | |
| 2,070,851 | | |
| 1,461,792 | |
| TOTAL
LIABILITIES | |
| 2,070,851 | | |
| 1,461,792 | |
| Shareholders’
Equity | |
| | | |
| | |
| Class A Ordinary Shares, $0.001 par value; 12,000,000,000 shares authorized; 296,488 and 119,000 shares issued and outstanding as of October 31, 2025 and 2024, respectively;* | |
| 296 | | |
| 119 | |
| Class B Ordinary Shares, $0.001 par value; 3,000,000,000 shares authorized; 381,000 shares issued and outstanding as of October 31, 2025 and 2024, respectively* | |
| 381 | | |
| 381 | |
| Subscription
Receivable | |
| — | | |
| — | |
| Additional
Paid In Capital | |
| 28,021,581 | | |
| 1,161,211 | |
| Statutory
Reserve | |
| 217,264 | | |
| 131,962 | |
| (Accumulated
Deficits) Retained Earning | |
| (24,178,267 | ) | |
| 271,788 | |
| Accumulated
Other Comprehensive Loss | |
| (66,400 | ) | |
| (59,376 | ) |
| Total
Stockholders’ Equity | |
| 3,994,855 | | |
| 1,506,085 | |
| TOTAL
LIABILITIES AND SHAREHOLDERS’ EQUITY | |
| 6,065,706 | | |
| 2,967,877 | |
|
| Schedule of Statements of Operations |
Condensed
Statements of Operations
| | |
Year
Ended
October 31,
2025 | | |
Year
Ended
October 31,
2024 | | |
Year
Ended
October 31,
2023 | |
| Operating costs and expenses: | |
| | | |
| | | |
| | |
| General and administrative expenses | |
| 24,840,917 | | |
| 373,892 | | |
| — | |
| Total operating expenses | |
| 24,840,917 | | |
| — | | |
| — | |
| Other income (expense): | |
| — | | |
| — | | |
| — | |
| Other income | |
| 30,002 | | |
| — | | |
| — | |
| Interest income | |
| 2,552 | | |
| — | | |
| — | |
| Interest expense | |
| (41 | ) | |
| — | | |
| — | |
| Total other income (expenses) | |
| 32,513 | | |
| — | | |
| — | |
| Income of subsidiaries
and VIEs | |
| 443,651 | | |
| 852,453 | | |
| 852,042 | |
| Net (loss) income | |
| (24,364,753 | ) | |
| 478,561 | | |
| 852,042 | |
|
| Schedule of Cash Flow Statement |
| | |
Year Ended
October 31,
2025 | | |
Year Ended
October 31,
2024 | | |
Year Ended
October 31,
2023 | |
| Cash flows from operating activities | |
| | | |
| | | |
| | |
| Net
(loss) income | |
| (24,364,753 | ) | |
| 478,561 | | |
| 852,042 | |
| Share-based
Compensation Expense | |
| 24,070,200 | | |
| — | | |
| — | |
| Other
non-cash operating expense | |
| 150,000 | | |
| 373,892 | | |
| — | |
| Income
of subsidiaries and VIEs | |
| (443,651 | ) | |
| (852,453 | ) | |
| (852,042 | ) |
| Changes
in operating assets and liabilities: | |
| | | |
| | | |
| | |
| Other
receivables and other current assets | |
| (293,333 | ) | |
| — | | |
| — | |
| Accruals
and other payables | |
| 60,000 | | |
| — | | |
| — | |
| | |
| | | |
| | | |
| | |
| Net
cash used in operating activities | |
| (821,537 | ) | |
| — | | |
| — | |
| | |
| | | |
| | | |
| | |
| Cash
flows from investing activities | |
| | | |
| | | |
| | |
| Pay
the investments on behalf of the subsidiary | |
| (1,400,000 | ) | |
| — | | |
| — | |
| Loans
to the third party | |
| (6,030,001 | ) | |
| — | | |
| — | |
| Loans
repayment from the third party | |
| 6,030,001 | | |
| — | | |
| — | |
| Net
cash used in investing activities | |
| (1,400,000 | ) | |
| — | | |
| — | |
| | |
| | | |
| | | |
| | |
| Cash
flows from financing activities | |
| | | |
| | | |
| | |
| Proceeds from issuance
of shares | |
| 4,277,807 | | |
| — | | |
| — | |
| Net
cash provided by financing activities | |
| 4,277,807 | | |
| — | | |
| — | |
| | |
| | | |
| | | |
| | |
| Net
increase in cash | |
| 2,056,270 | | |
| — | | |
| — | |
| | |
| | | |
| | | |
| | |
| Effect
of exchange rate changes on cash | |
| — | | |
| — | | |
| — | |
| Cash and
cash equivalents– at the beginning of the year | |
| — | | |
| — | | |
| — | |
| Cash and
cash equivalents– at the end of the year | |
$ | 2,056,270 | | |
$ | — | | |
$ | — | |
|